Rapid Diagnostic Test for Identifying Group B Streptococcus

ABSTRACT

Neonatal infection with Streptococcus agalactiae (group B streptococcus [GBS]) causes significant morbidity and mortality. A truly rapid diagnostic test for identifying GBS would allow for more timely initiation of antibiotic prophylaxis and also reduce the administration of antibiotics for the prevention of early onset neonatal GBS infection. A stock culture was formed from a laboratory reference strain of GBS and was diluted from 10⁷ to 10¹ bacteria/mL. Specific concentrations were used to inoculate nitrocellulose membranes (NCMs) that had been coated previously with polyclonal rabbit antibody against GBS. After specific times, the NCMs were removed from the sheep blood agar medium, and horseradish-peroxidase conjugate polyclonal antibody against GBS was added. Bound antibody was detected with diaminobenzidine. After 6 hours of incubation, GBS was detected at concentrations from 10⁷ through 10⁴ bacterial/mL. After 4 hours of incubation, GBS was detected at concentrations from 10⁷ through 10⁵ bacteria/mL. GBS was not detected at 2 hours of incubation. Rapid growth and detection of GBS can be performed, and the results can be reliably attained as early as 4 hours. This is in marked contrast to the 48 to 72 hours required by current methods.

KEYWORDS

GBS - rapid diagnostic test - colonization - pregnancy

REFERENCES

• 1 Koenig J M, Keenan W J. Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis.  Pediatr Clin North Am. 2009;  56 689-708
• 2 Faro S. Group B streptococcus and puerperal sepsis.  Am J Obstet Gynecol. 1980;  138 1219-1220
• 3 Faro S, Brehm B, Smith F et al.. Screening for group B streptococcus: a private hospital's experience.  Infect Dis Obstet Gynecol. 2010;  2010:pii:451096
• 4 Verani J R, McGee L, Schrag S J. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC) . Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010.  MMWR Recomm Rep. 2010;  59 (RR-10) 1-36
• 5 Daniels J, Gray J, Pattison H et al.. Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness.  Health Technol Assess. 2009;  13 1-154 iii-iv
• 6 Davies H D, Miller M A, Faro S, Gregson D, Kehl S C, Jordan J A. Multicenter study of a rapid molecular-based assay for the diagnosis of group B streptococcus colonization in pregnant women.  Clin Infect Dis. 2004;  39 1129-1135
• 7 Aziz N, Baron E J, D'Souza H, Nourbakhsh M, Druzin M L, Benitz W E. Comparison of rapid intrapartum screening methods for group B streptococcal vaginal colonization.  J Matern Fetal Neonatal Med. 2005;  18 225-229
• 8 Jordan J A, Hall G, Davis T. Multicenter study evaluating performance of the Smart Group B Streptococcus (GBS) assay using an enrichment protocol for detecting GBS colonization in patients in the antepartum period.  J Clin Microbiol. 2010;  48 3193-3197
• 9 Wilson D A, Hall G S, Procop G W. Detection of group B streptococcus bacteria in LIM enrichment broth by peptide nucleic acid fluorescent in situ hybridization (PNA FISH) and rapid cycle PCR.  J Clin Microbiol. 2010;  48 1947-1948
• 10 Riedlinger J, Beqaj S H, Milish M A et al.. Multicenter evaluation of the BD Max GBS assay for detection of group B streptococci in prenatal vaginal and rectal screening swab specimens from pregnant women.  J Clin Microbiol. 2010;  48 4239-4241
• 11 Rogers J V, Choi Y W. Decreased time for detection and quantification of virulent Bacillus anthracis and Yersinia pestis using a BioNanoPore (BNP) membrane technology.  Lett Appl Microbiol. 2009;  48 793-796